SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001477932-21-006040
Filing Date
2021-08-30
Accepted
2021-08-30 16:15:30
Documents
2
Period of Report
2021-08-24
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K thct_8k.htm 8-K 17703
2 ENGAGEMENT AGREEMENT thct_ex101.htm EX-10.1 23653
  Complete submission text file 0001477932-21-006040.txt   42900
Mailing Address 11700 W CHARLESTON BLVD #73 LAS VEGAS NV 89135
Business Address 11700 W CHARLESTON BLVD #73 LAS VEGAS NV 89135 833-420-8428
THC Therapeutics, Inc. (Filer) CIK: 0001404935 (see all company filings)

IRS No.: 260164981 | Fiscal Year End: 0729
Type: 8-K | Act: 34 | File No.: 000-55994 | Film No.: 211223679
SIC: 3523 Farm Machinery & Equipment